LEADER 03200oam 22006735 450 001 9910825860903321 005 20200520144314.0 010 $a1-283-29262-9 010 $a9786613292629 010 $a0-8213-8771-5 024 7 $a10.1596/978-0-8213-8760-3 035 $a(CKB)2550000000049806 035 $a(EBL)783538 035 $a(OCoLC)756484483 035 $a(SSID)ssj0000566925 035 $a(PQKBManifestationID)12199746 035 $a(PQKBTitleCode)TC0000566925 035 $a(PQKBWorkID)10562287 035 $a(PQKB)11670119 035 $a(MiAaPQ)EBC783538 035 $a(Au-PeEL)EBL783538 035 $a(CaPaEBR)ebr10506408 035 $a(CaONFJC)MIL329262 035 $a(DNLM)101556613 035 $a(The World Bank)2011012020 035 $a(US-djbf)16706676 035 $a(EXLCZ)992550000000049806 100 $a20110317d2011 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPharmaceutical reform : $ea guide to improving performance and equity /$fMarc J. Roberts and Michael R. Reich 210 1$aWashington, D.C. :$cWorld Bank,$dc2011. 215 $axx, 332 pages $cillustrations ;$d24 cm 225 1 $aWorld Bank Training 300 $aDescription based upon print version of record. 311 $a0-8213-8760-X 320 $aIncludes bibliographical references and index. 327 $aIntroduction -- Using the flagship framework to reform pharmaceutical policy -- Introduction to the pharmaceutical sector -- Ethics and priority setting in pharmaceutical reform -- Diagnosing performance problems and developing a policy response -- Managing the politics of pharmaceutical policy reform -- Financing the pharmaceutical sector -- Paying for pharmaceuticals -- Organizing the public sector to improve pharmaceutical performance -- Improving pharmaceutical performance through regulation -- Using persuasion to influence pharmaceutical use -- Conclusions. 330 $aThis book applies an established analytical framework for health sector reform (Getting Health Reform Right, Oxford, 2004) to the performance problems of the pharmaceutical sector. The book is divided into three sections. The first section presents the basic ideas for analysis. It begins by insisting that reform start with a clear understanding of the performance deficiencies of the current system. Like all priority setting in the public sector, this 'definition of the problem' involves both ethical choices and political processes. Early chapters explain the foundations of these ideas and appl 410 0$aWorld Bank e-Library. 606 $aPharmaceutical policy 606 $aPharmaceutical industry 606 $aHealth care reform 615 0$aPharmaceutical policy. 615 0$aPharmaceutical industry. 615 0$aHealth care reform. 676 $a615.1 700 $aRoberts$b Marc J$0507890 701 $aReich$b Michael$f1950-$0119700 712 02$aWorld Bank. 801 0$bDNLM/DLC 801 1$bDLC 906 $aBOOK 912 $a9910825860903321 996 $aPharmaceutical reform$93920551 997 $aUNINA